1. Home
  2. GKOS vs LPL Comparison

GKOS vs LPL Comparison

Compare GKOS & LPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • LPL
  • Stock Information
  • Founded
  • GKOS 1998
  • LPL 1985
  • Country
  • GKOS United States
  • LPL South Korea
  • Employees
  • GKOS N/A
  • LPL N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • LPL Industrial Machinery/Components
  • Sector
  • GKOS Health Care
  • LPL Technology
  • Exchange
  • GKOS Nasdaq
  • LPL Nasdaq
  • Market Cap
  • GKOS 5.4B
  • LPL 4.5B
  • IPO Year
  • GKOS 2015
  • LPL 2004
  • Fundamental
  • Price
  • GKOS $84.11
  • LPL $5.41
  • Analyst Decision
  • GKOS Strong Buy
  • LPL Sell
  • Analyst Count
  • GKOS 13
  • LPL 3
  • Target Price
  • GKOS $121.46
  • LPL N/A
  • AVG Volume (30 Days)
  • GKOS 864.7K
  • LPL 637.8K
  • Earning Date
  • GKOS 11-03-2025
  • LPL 10-22-2025
  • Dividend Yield
  • GKOS N/A
  • LPL N/A
  • EPS Growth
  • GKOS N/A
  • LPL N/A
  • EPS
  • GKOS N/A
  • LPL N/A
  • Revenue
  • GKOS $432,953,000.00
  • LPL $19,437,582,152.00
  • Revenue This Year
  • GKOS $28.90
  • LPL N/A
  • Revenue Next Year
  • GKOS $25.57
  • LPL N/A
  • P/E Ratio
  • GKOS N/A
  • LPL N/A
  • Revenue Growth
  • GKOS 26.70
  • LPL 8.96
  • 52 Week Low
  • GKOS $77.10
  • LPL $2.43
  • 52 Week High
  • GKOS $163.71
  • LPL $5.49
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.81
  • LPL 72.09
  • Support Level
  • GKOS $79.02
  • LPL $5.35
  • Resistance Level
  • GKOS $89.29
  • LPL $5.30
  • Average True Range (ATR)
  • GKOS 3.19
  • LPL 0.10
  • MACD
  • GKOS 0.54
  • LPL 0.03
  • Stochastic Oscillator
  • GKOS 49.76
  • LPL 88.36

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.

Share on Social Networks: